Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Several new studies show how exercise can extend cancer patients’ survival, reduce the risk of recurrence, and improve quality...
The New Drugs on the Horizon sessions at AACR Annual Meeting 2025 unveiled 12 novel cancer therapeutics and discussed...
This month, the editors of AACR’s journals picked studies highlighting genetic parallels between cancer evolution and high-altitude physiology, data...
The AACR Annual Meeting 2025, held April 25-30, featured six Plenary Sessions that explored exciting areas of cancer research,...
At the AACR Annual Meeting 2025, experts offered strategies on how to overcome the challenges within the oncology drug...
The latest edition of From the Bench features creative cancer research, including making tumors seem like pig organs, starving...
At the AACR Annual Meeting 2025, researchers and patient advocates shared insights into the impact of NIH funding cuts...
Learn how a Gleason score is calculated to help determine the aggressiveness of prostate cancer, and how it could...
Research unveiled at the AACR Annual Meeting 2025 highlighted advances in blood-based liquid biopsy tests to help improve cancer...
Clinical trial results reported at the AACR Annual Meeting 2025 showcased new therapeutic approaches for non-small cell lung cancer....